TAVI AS THE INITIAL STEP IN A LONG-TERM TREATMENT STRATEGY: THE DYNAMICS OF PSYCHOSOCIAL OUTCOMES, THE ROLE OF SHARED DECISION-MAKING, AND TELEMEDICAL INNOVATIONS– A NARRATIVE REVIEW
DOI:
https://doi.org/10.31435/ijitss.2(50).2026.6074Keywords:
Transcatheter Aortic Valve Implantation (TAVI), Health-Related Quality of Life (HRQoL), E-Health, Telemedicine, Wearable Technology, Psychosocial Well-Being, Low-Risk Patients, Shared Decision-MakingAbstract
Background: Transcatheter aortic valve implantation (TAVI) has evolved from a life-saving procedure for inoperable patients into a widespread standard, increasingly encompassing younger and low-surgical-risk populations. This paradigm shift, reflected in current clinical guidelines, necessitates a renewed focus on health-related quality of life (HRQoL), cognitive function, and the return to social roles.
Aim: This study aims to evaluate the psychosocial and cognitive trajectories of both geriatric and non-geriatric patients following TAVI, and to analyze the impact of digital technologies (e-Health) on long-term postoperative care and cardiac rehabilitation.
Methods: A narrative literature review was conducted, incorporating recent cardiological guidelines and studies regarding clinical qualification, cognitive changes, and the application of telemedicine.
Results: TAVI significantly improves patients' quality of life. However, age-dependent challenges are evident: geriatric patients require routine screening for frailty and cognitive impairment, whereas younger populations experience specific psychological stress related to valve durability and the prospect of future valve-in-valve procedures. Modern wearable technologies (e.g., smartwatches) effectively facilitate remote health management and a safe return to physical activity in both groups.
Conclusion: Modern qualification for TAVI should be based on shared decision-making. Comprehensive postoperative care must extend beyond hemodynamic parameters by integrating digital health monitoring to optimize psychosocial support.
References
Adams, D. H., Popma, J. J., Reardon, M. J., Yakubov, S. J., Coselli, J. S., Deeb, G. M., Gleason, T. G., Buchbinder, M., Hermiller, J., Jr., Kleiman, N. S., Chetcuti, S., Heiser, J., Merhi, W., Zorn, G., Tadros, P., Robinson, N., Petrossian, G., Hughes, G. C., Harrison, J. K., Conte, J., . . . U.S. CoreValve Clinical Investigators. (2014). Transcatheter aortic-valve replacement with a self-expanding prosthesis. The New England Journal of Medicine, 370(19), 1790–1798. https://doi.org/10.1056/NEJMoa1400590
Baumgartner, H., Falk, V., Bax, J. J., De Bonis, M., Hamm, C., Holm, P. J., Iung, B., Lancellotti, P., Lansac, E., Rodriguez Muñoz, D., Rosenhek, R., Sjögren, J., Tornos Mas, P., Vahanian, A., Walther, T., Wendler, O., Windecker, S., Zamorano, J. L., & ESC Scientific Document Group. (2017). 2017 ESC/EACTS guidelines for the management of valvular heart disease. European Heart Journal, 38(36), 2739–2791. https://doi.org/10.1093/eurheartj/ehx391
Coylewright, M., O’Neill, E., Sherman, A., Gerling, M., Adam, K., Xu, K., Grande, S. W., Dauerman, H. L., Dodge, S. E., Sobti, N. K., Saunders, C. H., Schott, S. L., Elwyn, G., & Durand, M. A. (2020). The learning curve for shared decision-making in symptomatic aortic stenosis. JAMA Cardiology, 5(4), 442–448. https://doi.org/10.1001/jamacardio.2019.5719
Gargiulo, G., Sannino, A., Capodanno, D., Barbanti, M., Buccheri, S., Perrino, C., Capranzano, P., Indolfi, C., Trimarco, B., Tamburino, C., & Esposito, G. (2016). Transcatheter aortic valve implantation versus surgical aortic valve replacement: A systematic review and meta-analysis. Annals of Internal Medicine, 165(5), 334–344. https://doi.org/10.7326/M16-0060
Généreux, P., Head, S. J., Van Mieghem, N. M., Kodali, S., Kirtane, A. J., Xu, K., Smith, C., Serruys, P. W., Kappetein, A. P., & Leon, M. B. (2012). Clinical outcomes after transcatheter aortic valve replacement using Valve Academic Research Consortium definitions: A weighted meta-analysis of 3,519 patients from 16 studies. Journal of the American College of Cardiology, 59(25), 2317–2326. https://doi.org/10.1016/j.jacc.2012.02.022
Ghanem, A., Kocurek, J., Sinning, J. M., Wagner, M., Becker, B. V., Vogel, M., Schröder, T., Wolfsgruber, S., Vasa-Nicotera, M., Hammerstingl, C., Schwab, J. O., Thomas, D., Werner, N., Grube, E., Nickenig, G., & Müller, A. (2013). Cognitive trajectory after transcatheter aortic valve implantation. Circulation: Cardiovascular Interventions, 6(6), 615–624. https://doi.org/10.1161/CIRCINTERVENTIONS.112.000429
Kapadia, M., Shi, S. M., Afilalo, J., Popma, J. J., Laham, R. J., Guibone, K., & Kim, D. H. (2020). Cognition, frailty, and functional outcomes of transcatheter aortic valve replacement. The American Journal of Medicine, 133(10), 1219–1222. https://doi.org/10.1016/j.amjmed.2020.01.041
Kapadia, S. R., Leon, M. B., Makkar, R. R., Tuzcu, E. M., Svensson, L. G., Kodali, S., Webb, J. G., Mack, M. J., Douglas, P. S., Thourani, V. H., Babaliaros, V. C., Herrmann, H. C., Szeto, W. Y., Pichard, A. D., Williams, M. R., Fontana, G. P., Miller, D. C., Anderson, W. N., Akin, J. J., Davidson, M. J., . . . PARTNER Trial Investigators. (2015). 5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): A randomised controlled trial. The Lancet, 385(9986), 2485–2491. https://doi.org/10.1016/S0140-6736(15)60290-2
Khan, M. M., Lanctôt, K. L., Fremes, S. E., Wijeysundera, H. C., Radhakrishnan, S., Gallagher, D., Gandell, D., Brenkel, M. C., Hazan, E. L., Docteur, N. G., & Herrmann, N. (2019). The value of screening for cognition, depression, and frailty in patients referred for TAVI. Clinical Interventions in Aging, 14, 841–848. https://doi.org/10.2147/CIA.S201615
Kheiri, B., Osman, M., Abubakar, H., Subahi, A., Chahine, A., Ahmed, S., Bachuwa, G., Alkotob, M. L., Hassan, M., & Bhatt, D. L. (2019). Transcatheter versus surgical aortic valve replacement in low-risk surgical patients: A meta-analysis of randomized clinical trials. Cardiovascular Revascularization Medicine, 20(10), 838–842. https://doi.org/10.1016/j.carrev.2018.12.023
Kolte, D., Vlahakes, G. J., Palacios, I. F., Sakhuja, R., Passeri, J. J., Inglessis, I., & Elmariah, S. (2019). Transcatheter versus surgical aortic valve replacement in low-risk patients. Journal of the American College of Cardiology, 74(12), 1532–1540. https://doi.org/10.1016/j.jacc.2019.06.076
Lauck, S. B., Yu, M., Ding, L., Hardiman, S., Wong, D., Sathananthan, J., Ye, J., Chan, A., Hodge, S., Robinson, S., Wood, D. A., & Webb, J. G. (2021). Quality-of-life outcomes after transcatheter aortic valve implantation in a “real world” population: Insights from a prospective Canadian database. CJC Open, 3(8), 1033–1042. https://doi.org/10.1016/j.cjco.2021.04.006
Leon, M. B., Mack, M. J., Pibarot, P., Hahn, R. T., Thourani, V. H., Kodali, S. H., Généreux, P., Kapadia, S. R., Cohen, D. J., Pocock, S. J., Zhang, Y., Szerlip, M., Ternacle, J., Malaisrie, S. C., Herrmann, H. C., Szeto, W. Y., Russo, M. J., Babaliaros, V., Nazif, T., Webb, J. G., . . . PARTNER 3 Investigators. (2026). Transcatheter or surgical aortic-valve replacement in low-risk patients at 7 years. The New England Journal of Medicine, 394(8), 773–783. https://doi.org/10.1056/NEJMoa2509766
Liu, X., Fan, J., Guo, Y., Dai, H., Xu, J., Wang, L., Hu, P., Lin, X., Li, C., Zhou, D., Li, H., & Wang, J. (2022). Wearable smartwatch facilitated remote health management for patients undergoing transcatheter aortic valve replacement. Journal of the American Heart Association, 11(7), Article e023219. https://doi.org/10.1161/JAHA.121.023219
Mack, M. J., Leon, M. B., Thourani, V. H., Makkar, R., Kodali, S. K., Russo, M., Kapadia, S. R., Malaisrie, S. C., Cohen, D. J., Pibarot, P., Leipsic, J., Hahn, R. T., Blanke, P., Williams, M. R., McCabe, J. M., Brown, D. L., Babaliaros, V., Goldman, S., Szeto, W. Y., Genereux, P., . . . PARTNER 3 Investigators. (2019). Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. The New England Journal of Medicine, 380(18), 1695–1705. https://doi.org/10.1056/NEJMoa1814052
Makkar, R. R., Thourani, V. H., Mack, M. J., Kodali, S. K., Kapadia, S., Webb, J. G., Yoon, S. H., Trento, A., Svensson, L. G., Herrmann, H. C., Szeto, W. Y., Miller, D. C., Satler, L., Cohen, D. J., Dewey, T. M., Babaliaros, V., Williams, M. R., Kereiakes, D. J., Zajarias, A., Greason, K. L., . . . PARTNER 2 Investigators. (2020). Five-year outcomes of transcatheter or surgical aortic-valve replacement. The New England Journal of Medicine, 382(9), 799–809. https://doi.org/10.1056/NEJMoa1910555
Marcusohn, E., Manoragavan, R., Fremes, S., Tarola, C., Sathananthan, J., Barabash, I. M., Orbach, A., Sachedina, A. K., Radhakrishnan, S., & Wijeysundera, H. C. (2024). Impact of cerebral protection on observed versus predicted in-hospital stroke in a high stroke risk TAVR cohort. BMC Cardiovascular Disorders, 24(1), Article 422. https://doi.org/10.1186/s12872-024-04097-2
Musa, T. A., Uddin, A., Loveday, C., Dobson, L. E., Igra, M., Richards, F., Swoboda, P. P., Singh, A., Garg, P., Foley, J. R. J., Fent, G. J., Goddard, A. J. P., Malkin, C., Plein, S., Blackman, D. J., McCann, G. P., & Greenwood, J. P. (2019). Silent cerebral infarction and cognitive function following TAVI: An observational two-centre UK comparison of the first-generation CoreValve and second-generation Lotus valve. BMJ Open, 9(1), Article e022329. https://doi.org/10.1136/bmjopen-2018-022329
Nishimura, R. A., Otto, C. M., Bonow, R. O., Carabello, B. A., Erwin, J. P., III, Fleisher, L. A., Jneid, H., Mack, M. J., McLeod, C. J., O’Gara, P. T., Rigolin, V. H., Sundt, T. M., III, & Thompson, A. (2017). 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation, 135(25), e1159–e1195. https://doi.org/10.1161/CIR.0000000000000503
Omboni, S., Benczur, B., & McManus, R. J. (2021). Editorial: Digital health in cardiovascular medicine. Frontiers in Cardiovascular Medicine, 8, Article 810992. https://doi.org/10.3389/fcvm.2021.810992
O’Neill, W. W., Kleiman, N. S., Moses, J., Henriques, J. P., Dixon, S., Massaro, J., Palacios, I., Maini, B., Mulukutla, S., Dzavík, V., Popma, J., Douglas, P. S., & Ohman, M. (2012). A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: The PROTECT II study. Circulation, 126(14), 1717–1727. https://doi.org/10.1161/CIRCULATIONAHA.112.098194
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., III, Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., O’Gara, P. T., Rigolin, V. H., Sundt, T. M., III, Thompson, A., & Toly, C. (2021). 2020 ACC/AHA guideline for the management of patients with valvular heart disease: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 143(5), e72–e227. https://doi.org/10.1161/CIR.0000000000000923
Parma, R., Zembala, M. O., Dąbrowski, M., Jagielak, D., Witkowski, A., Suwalski, P., Dudek, D., Olszówka, P., Wojakowski, W., Przybylski, R., Gil, R., Kuśmierczyk, M., Lesiak, M., Sadowski, J., Dobrzycki, S., Ochała, A., Hoffman, P., Kapelak, B., Kaźmierczak, J., Jasiński, M., . . . Różański, J. (2017). Transcatheter aortic valve implantation: Expert consensus of the Association of Cardiovascular Interventions of the Polish Cardiac Society and the Polish Society of Cardio-Thoracic Surgeons, approved by the Board of the Polish Cardiac Society. Kardiologia Polska, 75(9), 937–964. https://doi.org/10.5603/KP.2017.0175
Patel, K. V., Omar, W., Gonzalez, P. E., Jessen, M. E., Huffman, L., Kumbhani, D. J., & Bavry, A. A. (2020). Expansion of TAVR into low-risk patients and who to consider for SAVR. Cardiology and Therapy, 9(2), 377–394. https://doi.org/10.1007/s40119-020-00198-z
Puri, R., Chamandi, C., Rodriguez-Gabella, T., & Rodés-Cabau, J. (2018). Future of transcatheter aortic valve implantation—Evolving clinical indications. Nature Reviews Cardiology, 15(1), 57–65. https://doi.org/10.1038/nrcardio.2017.116
Reardon, M. J., Van Mieghem, N. M., Popma, J. J., Kleiman, N. S., Søndergaard, L., Mumtaz, M., Adams, D. H., Deeb, G. M., Maini, B., Gada, H., Chetcuti, S., Gleason, T., Heiser, J., Lange, R., Merhi, W., Oh, J. K., Olsen, P. S., Piazza, N., Williams, M., Windecker, S., . . . SURTAVI Investigators. (2017). Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. The New England Journal of Medicine, 376(14), 1321–1331. https://doi.org/10.1056/NEJMoa1700456
Rodés-Cabau, J., Webb, J. G., Cheung, A., Ye, J., Dumont, E., Feindel, C. M., Osten, M., Natarajan, M. K., Velianou, J. L., Martucci, G., DeVarennes, B., Chisholm, R., Peterson, M. D., Lichtenstein, S. V., Nietlispach, F., Doyle, D., DeLarochellière, R., Teoh, K., Chu, V., Dancea, A., . . . Horlick, E. (2010). Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: Acute and late outcomes of the multicenter Canadian experience. Journal of the American College of Cardiology, 55(11), 1080–1090. https://doi.org/10.1016/j.jacc.2009.12.014
Salinas, P., Moreno, R., & Lopez-Sendon, J. L. (2011). Transcatheter aortic valve implantation: Current status and future perspectives. World Journal of Cardiology, 3(6), 177–185. https://doi.org/10.4330/wjc.v3.i6.177
Søndergaard, L., Ihlemann, N., Capodanno, D., Jørgensen, T. H., Nissen, H., Kjeldsen, B. J., Chang, Y., Steinbrüchel, D. A., Olsen, P. S., Petronio, A. S., & Thyregod, H. G. H. (2019). Durability of transcatheter and surgical bioprosthetic aortic valves in patients at lower surgical risk. Journal of the American College of Cardiology, 73(5), 546–553. https://doi.org/10.1016/j.jacc.2018.10.083
Tam, D. Y., Azizi, P. M., Fremes, S. E., Chikwe, J., Gaudino, M., & Wijeysundera, H. C. (2021). The cost-effectiveness of transcatheter aortic valve replacement in low surgical risk patients with severe aortic stenosis. European Heart Journal—Quality of Care and Clinical Outcomes, 7(6), 556–563. https://doi.org/10.1093/ehjqcco/qcaa058
Thourani, V. H., Kodali, S., Makkar, R. R., Herrmann, H. C., Williams, M., Babaliaros, V., Smalling, R., Lim, S., Malaisrie, S. C., Kapadia, S., Szeto, W. Y., Greason, K. L., Kereiakes, D., Ailawadi, G., Whisenant, B. K., Devireddy, C., Leipsic, J., Hahn, R. T., Pibarot, P., Weissman, N. J., . . . Leon, M. B. (2016). Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: A propensity score analysis. The Lancet, 387(10034), 2218–2225. https://doi.org/10.1016/S0140-6736(16)30073-3
Thyregod, H. G., Steinbrüchel, D. A., Ihlemann, N., Nissen, H., Kjeldsen, B. J., Petursson, P., Chang, Y., Franzen, O. W., Engstrøm, T., Clemmensen, P., Hansen, P. B., Andersen, L. W., Olsen, P. S., & Søndergaard, L. (2015). Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. Journal of the American College of Cardiology, 65(20), 2184–2194. https://doi.org/10.1016/j.jacc.2015.03.014
Thyregod, H. G. H., Ihlemann, N., Jørgensen, T. H., Nissen, H., Kjeldsen, B. J., Petursson, P., Chang, Y., Franzen, O. W., Engstrøm, T., Clemmensen, P., Hansen, P. B., Andersen, L. W., Steinbrüchel, D. A., Olsen, P. S., & Søndergaard, L. (2019). Five-year clinical and echocardiographic outcomes from the NOTION randomized clinical trial in patients at lower surgical risk. Circulation, 139(24), 2714–2723. https://doi.org/10.1161/CIRCULATIONAHA.118.036606
Vahanian, A., Beyersdorf, F., Praz, F., Milojevic, M., Baldus, S., Bauersachs, J., Capodanno, D., Conradi, L., De Bonis, M., De Paulis, R., Delgado, V., Freemantle, N., Gilard, M., Haugaa, K. H., Jeppsson, A., Jüni, P., Pierard, L., Prendergast, B. D., Sádaba, J. R., Tribouilloy, C., . . . ESC/EACTS Scientific Document Group. (2022). 2021 ESC/EACTS guidelines for the management of valvular heart disease. European Heart Journal, 43(7), 561–632. https://doi.org/10.1093/eurheartj/ehab395
Van Belle, E., Juthier, F., Susen, S., Vincentelli, A., Iung, B., Dallongeville, J., Eltchaninoff, H., Laskar, M., Leprince, P., Lievre, M., Banfi, C., Auffray, J. L., Delhaye, C., Donzeau-Gouge, P., Chevreul, K., Fajadet, J., Leguerrier, A., Prat, A., Gilard, M., Teiger, E., . . . FRANCE 2 Investigators. (2014). Postprocedural aortic regurgitation in balloon-expandable and self-expandable transcatheter aortic valve replacement procedures: Analysis of predictors and impact on long-term mortality—Insights from the FRANCE 2 Registry. Circulation, 129(13), 1415–1427. https://doi.org/10.1161/CIRCULATIONAHA.113.002677
Waksman, R., Rogers, T., Torguson, R., Gordon, P., Ehsan, A., Wilson, S. R., Goncalves, J., Levitt, R., Hahn, C., Parikh, P., Bilfinger, T., Butzel, D., Buchanan, S., Hanna, N., Garrett, R., Asch, F., Weissman, G., Ben-Dor, I., Shults, C., Bastian, R., . . . Corso, P. J. (2018). Transcatheter aortic valve replacement in low-risk patients with symptomatic severe aortic stenosis. Journal of the American College of Cardiology, 72(18), 2095–2105. https://doi.org/10.1016/j.jacc.2018.08.1033
Webb, J. G., Mack, M. J., White, J. M., Dvir, D., Blanke, P., Herrmann, H. C., Leipsic, J., Kodali, S. K., Makkar, R., Miller, D. C., Pibarot, P., Pichard, A., Satler, L. F., Svensson, L., Alu, M. C., Suri, R. M., & Leon, M. B. (2017). Transcatheter aortic valve implantation within degenerated aortic surgical bioprostheses: PARTNER 2 valve-in-valve registry. Journal of the American College of Cardiology, 69(18), 2253–2262. https://doi.org/10.1016/j.jacc.2017.02.057
Zou, J., Yuan, J., Liu, J., & Geng, Q. (2023). Impact of cardiac rehabilitation on pre- and postoperative transcatheter aortic valve replacement prognoses. Frontiers in Cardiovascular Medicine, 10, Article 1164104. https://doi.org/10.3389/fcvm.2023.1164104
Downloads
Published
Issue
Section
License
Copyright (c) 2026 Klaudia Jurkowska
This work is licensed under a Creative Commons Attribution 4.0 International License.
All articles are published in open-access and licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0). Hence, authors retain copyright to the content of the articles.
CC BY 4.0 License allows content to be copied, adapted, displayed, distributed, re-published or otherwise re-used for any purpose including for adaptation and commercial use provided the content is attributed.
How to Cite
